The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of the Bcl-2 inhibitor venetoclax with DA-EPOCH-R as initial therapy for aggressive B-cell lymphomas.
 
Sarah C. Rutherford
Consulting or Advisory Role - AstraZeneca; BeiGene; Celgene; HERON; Juno Therapeutics; Karyopharm Therapeutics; Seagen; Verastem
Research Funding - Genentech (Inst); Karyopharm Therapeutics (Inst); LAM Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst)
 
Jeremy S. Abramson
Consulting or Advisory Role - Abbvie; Alimera Sciences; Alimera Sciences; Bayer; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck; MorphoSys; Novartis; Verastem
Research Funding - AI Therapeutics (Inst); Celgene (Inst); Seagen (Inst)
 
Nancy L. Bartlett
Consulting or Advisory Role - Seagen
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Stefan K. Barta
Honoraria - Mundipharma
Consulting or Advisory Role - Janssen Oncology; Seagen
Research Funding - Bayer (Inst); Celgene; Merck; Seagen; Takeda
Travel, Accommodations, Expenses - Curis
 
Nadia Khan
Consulting or Advisory Role - Janssen; Kite, a Gilead company; Seagen
 
Robin Joyce
Stock and Other Ownership Interests - Intellipharmaceutics
 
Kami J. Maddocks
Honoraria - Bayer; Celgene; Novartis; Pharmacyclics; Seagen; Teva
Research Funding - Bristol-Myers Squibb; Merck; Pharmacyclics
 
Ying Yuan
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - Boehringer Ingelheim; Midas Medical Technologies; Salzman Group
 
Trisha Ali-Shaw
No Relationships to Disclose
 
Silvia Senese
No Relationships to Disclose
 
Jason Westin
Consulting or Advisory Role - Amgen; Celgene; Curis; Genentech/Abbvie; Janssen Scientific Affairs; Juno Therapeutics; Juno Therapeutics; Kite/Gilead; MorphoSys; Novartis
Research Funding - Bristol-Myers Squibb; Celgene; Curis; Genentech; Janssen; Kite/Gilead; Novartis
 
John Paul Leonard
Consulting or Advisory Role - ADC Therapeutics; Akcea Therapeutics; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; MEI Pharma; Merck; Miltenyi Biotec; Morphosys; Nordic Nanovector; Nordic Nanovector; Regeneron; Sandoz; Sutter Medical Group
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Celgene (Inst); Janssen Oncology (Inst); National Cancer Institute (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BeiGene